Press Releases

PASADENA, Calif., May 15, 2024 /PRNewswire/ -- Huntington Medical Research Institutes (HMRI), a pioneer in scientific research dedicated to unraveling diseases of the heart and brain, gains new insights into dementia among American Indians for the first time through a landmark study led by renowned epidemiologist Astrid Suchy-Dicey, PhD, Associate Professor, and Scientific Director, Clinical and Translational Neurosciences.

... (continue reading...)

Glass Lewis Joins ISS in Recommending Xperi Stockholders Vote “FOR” All Company Nominees on the Blue Proxy Card

Glass Lewis Concludes Rubric Capital Has Failed to Make a Case for Change and “Full Support for the Incumbent Board is Warranted”

SAN JOSE, Calif.--(BUSINESS WIRE)-- Xperi Inc. (NYSE: XPER) (the “Company” or “Xperi”) today announced that a second independent proxy advisory firm, Glass, Lewis & Co., LLC (“Glass Lewis”), has... (continue reading...)

FALLS CHURCH, Va., May 15, 2024 /PRNewswire/ -- The EIFS Industry Members Association (EIMA) proudly announces the addition of three category-leading companies to its roster of associate members. Joining the ranks of industry leaders, Ames Tools Corporation, MKS Plastics, and New Cast Stone bring their expertise and innovation to further enrich the diverse landscape of EIMA's membership.

... (continue reading...)

LAUSANNE, Switzerland, May 15, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on Monday, May 20, 2024 at 2:00 p.m. ET.

A live webcast of the presentation will be available via the Events & Presentations page in the Investors section of ADC Therapeutics’ website ir.adctherapeutics.com. A... (continue reading...)

• Rare disease charity PTEN Research Foundation welcomes two new senior leaders from the pharmaceutical industry, Professor Sir Mene Pangalos and Dr Donald Ogilvie to the Foundation’s Scientific Advisory Board (SAB).

• By strengthening its scientific oversight, the Foundation hopes to further progress and accelerate its mission to fund and facilitate research that will lead to better treatments and improved outcomes for people with PTEN Hamartoma Tumour Syndrome... (continue reading...)